Last updated: May 27, 2023
Sponsor: University of Tehran
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pancreatitis
Treatment
Endoscopic necrosectomy
Clinical Study ID
NCT05530772
DDRI.1401.008
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Documented history of acute pancreatitis
- Necrotic collection with partial or complete wall diagnosed on CT or MRI
- Necrotic collection of any size with any number of loculations with more than 20% ofsolid/necrotic component
- Necrotic collection is accessible and amenable for EUS-guided drainage
- Age >= 18 years
- Suspected or confirmed infection in the necrotic collection
- The patient understands and accepts to sign the informed consent.
Exclusion
Exclusion Criteria:
- Irreversible coagulopathy with INR>1.5 or platelet counts <50,000
- Necrotic collection is not accessible for EUS-guided drainage
- Females who are pregnant
- Previous intervention (e,g, percutaneous drainage, or surgery) is performed for thepatient
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Endoscopic necrosectomy
Phase:
Study Start date:
September 12, 2022
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Digestive Diseases Research Institute, Shariati Hospital, North Kargar Ave.,
Tehran, 1411713135
Iran, Islamic Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.